Gallic acid serves as an effective therapeutic agent of inflammatory bowel disease: Pharmacological impacts on tight junction-dependent intestinal permeability in vivo and its related intracellular signaling

This publication has 67 references indexed in Scilit:

• Gallic acid mitigates lipopolysaccharide-induced testicular inflammation via regulation of the NF-κB and PK2/PKR1 pathway
  Journal of Molecular Histology, 2025
• Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review
  Inflammopharmacology, 2025
• Gallic acid ameliorates LPS-induced memory decline by modulating NF-κB, TNF-α, and Caspase 3 gene expression and attenuating oxidative stress and neuronal loss in the rat hippocampus
  Metabolic Brain Disease, 2024
• Solanum melongena L. Extract Promotes Intestinal Tight Junction Re‐Assembly via SIRT‐1‐Dependent Mechanisms
  Molecular Nutrition & Food Research, 2024
• Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease
  Molecular Diagnosis & Therapy, 2024
• Differentiating Between Tight Junction-Dependent and Tight Junction-Independent Intestinal Barrier Loss In Vivo
  2021
• Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis
  Molecular Neurobiology, 2019
• Gut microbiota in the pathogenesis of inflammatory bowel disease
  Clinical Journal of Gastroenterology, 2017
• Inhibitory Effect of Gallic Acid on Advanced Glycation End Products Induced Up-Regulation of Inflammatory Cytokines and Matrix Proteins in H9C2 (2-1) Cells
  Cardiovascular Toxicology, 2013
• Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasia
  Diseases of the Colon & Rectum, 1988